Michael Fox

Has grant

Director, Center for Brain Circuit Therapeutics

Brigham and Women's Hospital
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Transdiagnostic memory, mood and motor circuits in Alzheimer's and neurodegenerative disease

Open Date: 2021-04-15

Close Date: 2023-03-31

Grant: Close

Targeted modulation of symptom-specific brain circuits with transcranial magnetic stimulation

Open Date: 2021-04-01

Close Date: 2023-03-31

Grant: Close

Using human brain connectivity to identify the causal neuroanatomical substrate of depression symptoms

Open Date: 2017-09-19

Close Date: 2022-08-31

Grant: Close

Use of Resting-State Networks to Predict the Ideal Site for Brain Stimulation

Open Date: 2013-08-15

Close Date: 2018-05-31

Grant: Close

Functional Relevance of Spontaneous BOLD Fluctuations

Open Date: 2006-01-01

Close Date: 2008-05-16

Articles (20)

Year:

2025

Oculogyric crises are acute episodes of sustained, typically upward, conjugate deviation of the eyes. Oculogyric crises usually occur as the result of acute D2-dopamine receptor blockade, but the brain areas causally involved in generating this symptom remain elusive. Here, we used data from 14 previously reported cases of lesion-induced oculogyric crises and employed lesion network mapping to identify their shared connections throughout the brain. This analysis yielded a common network that included basal ganglia, thalamic, and brainstem nuclei, as well as the cerebellum. Comparison of this network with gene expression profiles associated with the dopamine system revealed spatial overlap specifically with the gene coding for dopamine receptor type 2 (DRD2) as defined by a large-scale transcriptomic database of the human brain. Furthermore, spatial overlap with DRD2 and DRD3 gene expression was specific to brain lesions associated with oculogyric crises when contrasted to lesions that led to other movement disorders. Our findings identify a common neural network causally involved in the occurrence of oculogyric crises and provide a pathophysiological link between lesion locations causing this syndrome and its most common pharmacological cause, namely DRD2 blockade.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (16)

Luis Concha

Professor

National Autonomous University of Mexico

View details

Patricia Krause

Charité - Universitätsmedizin Berlin

GERMANY
View details

Patricia Zvarova

Charité - Universitätsmedizin Berlin

GERMANY
View details

Aristotelis Kalyvas

Assistant Professor

University of Toronto

CANADA
View details

Gillian Coughlan

Assistant Professor

Massachusetts General Hospital and Harvard Medical School

UNITED STATES
View details

Maximilian Friedrich

Attending Neurologist | Research Group Leader

University Hospital Ulm

GERMANY
View details

Erica Baller

Assistant Professor of Psychiatry

University of Pennsylvania

UNITED STATES
View details

Frank Guenther

Professor

Boston University

UNITED STATES
View details

Markus D. Schirmer

Amsterdam University Medical Centers

UNITED KINGDOM
View details

Natalia Rost

Professor

Massachusetts General Hospital

UNITED STATES
View details

Christos Ganos

Director

-

GERMANY
View details

Wolf-Julian Neumann

Head of AI Innovation and Therapeutic Neurotechnology

Charité - Universitätsmedizin Berlin

GERMANY
View details

Richard Darby

Vanderbilt University Medical Center

UNITED STATES
View details

Esther Florin

Heinrich Heine University Düsseldorf

GERMANY
View details

Isaiah Kletenik

Assistant Professor of Neurology

Harvard Medical School

UNITED STATES
View details

Susanne van Veluw

University of Edinburgh

UNITED KINGDOM
View details